EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Real‐world outcomes of responsive neurostimulation in patients with Lennox–Gastaut syndrome: A multicenter retrospective study

Shanna M Swartwood iD, Robert J Bollo iD, Catherine J Chu iD, Alexandra L Geffrey, Robert Mark Richardson iD, Hiroki Nariai iD, Aria Fallah iD, Samuel Ahn iD, Saadi Ghatan, Laura Chenevert, Maite La Vega-Talbott, Audie C Espinoza

Epilepsia Open · 2026-08 · 11 (4) · 1244-1254

DOI: 10.1002/epi4.70283 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Epilepsia Open, online erschienen am 15.05.2026. Verfasst von Shanna M Swartwood und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Drug Resistant Epilepsy, Electric Stimulation Therapy, Implantable Neurostimulators. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Lennox–Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy (DEE) characterized by multiple seizure types and high resistance to antiseizure medication (ASM), often necessitating nonpharmacologic therapies, including neuromodulation. Responsive neurostimulation (RNS), a closed‐loop brain‐responsive neuromodulation device, has emerged as an adjunctive treatment option for drug‐resistant epilepsy (DRE), but evidence on its safety and effectiveness in LGS remains limited. This study examines real‐world outcomes of RNS therapy in patients with LGS‐associated DRE.

Methods

This retrospective multicenter study included patients with LGS who underwent RNS implantation before December 2024 across four Level 4 National Association of Epilepsy Centers (NAEC) in the United States. Demographic, clinical, surgical, and outcome data were systematically collected using a standardized case report form and analyzed.

Results

Thirty‐seven patients met inclusion criteria. At the time of RNS implantation, 95% of patients were pediatric (mean age 12.9 years, range 3.6–28.8) with a median follow‐up of 24.5 months. All patients had generalized tonic seizures; additional seizure types included tonic–clonic (62%), atonic (50%), atypical absence (19%), and other (54%). The pooled responder rate (≥50% seizure reduction) was 62%, including 10% with ≥90% reduction. Thalamic‐only stimulation of the bilateral centromedian nucleus (CMN) was the most common electrode configuration (76%), followed by cortico‐thalamic targeting to the CMN and bi‐frontal regions (18%). Among responders, 83% received thalamic‐only CMN stimulation. ASM reduction occurred in 10% of patients. Adverse events were reported in 13%, primarily implant‐related infections, with 4 patients requiring explantation. Stimulation‐related side effects occurred in 27% and resolved with programming adjustments in 80%. Significance RNS targeting thalamic and cortico‐thalamic networks resulted in seizure reduction in the majority of this predominantly pediatric LGS cohort. Therapy was generally well‐tolerated with few serious adverse events, supporting its potential role as an adjunctive treatment option for DRE in LGS. Plain Language Summary Lennox–Gastaut syndrome is a severe form of epilepsy that is often hard to control with medications. This study evaluated responsive neurostimulation (RNS), an implanted device that monitors brain activity and delivers electrical stimulation to help stop seizures before they spread. In 37 mostly pediatric patients, about 60% had their seizures reduced by at least half, and some improved even more. The treatment was generally safe, and most side effects could be managed by adjusting the device.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationDrug Resistant EpilepsyElectric Stimulation TherapyImplantable NeurostimulatorsLennox Gastaut SyndromeAdolescentAdultChildChild, PreschoolFemaleHumansMaleYoung AdultRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Lennox–Gastaut syndromedrug‐resistant epilepsyepilepsy surgeryneuromodulationpediatricresponsive neurostimulation

Autor:innen und Institutionen

  • Division of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Intermountain Healthcare, Salt Lake City, Utah, USA.
  • Division of Pediatric Neurosurgery, Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Kennedy Krieger Institute, Baltimore, Maryland, USA.

ORCID-Profile: Shanna M Swartwood, Robert J Bollo, Catherine J Chu, Robert Mark Richardson, Hiroki Nariai, Aria Fallah, Samuel Ahn

Förderung

  • NICHD NIH HHS

Zitieren

APA

Swartwood, S. M., Bollo, R. J., Chu, C. J., Geffrey, A. L., Richardson, R. M., Nariai, H., Fallah, A., Ahn, S., Ghatan, S., Chenevert, L., La Vega-Talbott, M., & Espinoza, A. C. (2026). Real‐world outcomes of responsive neurostimulation in patients with Lennox–Gastaut syndrome: A multicenter retrospective study. Epilepsia Open, 11(4), 1244-1254. https://doi.org/10.1002/epi4.70283

Vancouver

Swartwood SM, Bollo RJ, Chu CJ, Geffrey AL, Richardson RM, Nariai H, et al. Real‐world outcomes of responsive neurostimulation in patients with Lennox–Gastaut syndrome: A multicenter retrospective study. Epilepsia Open. 2026;11(4):1244-1254. doi:10.1002/epi4.70283

BibTeX
@article{Swartwood2026,
  author = {Swartwood, Shanna M and Bollo, Robert J and Chu, Catherine J and Geffrey, Alexandra L and Richardson, Robert Mark and Nariai, Hiroki and Fallah, Aria and Ahn, Samuel and Ghatan, Saadi and Chenevert, Laura and La Vega-Talbott, Maite and Espinoza, Audie C},
  title = {Real‐world outcomes of responsive neurostimulation in patients with Lennox–Gastaut syndrome: A multicenter retrospective study},
  journal = {Epilepsia Open},
  year = {2026},
  volume = {11},
  number = {4},
  pages = {1244--1254},
  doi = {10.1002/epi4.70283}
}
Kostenlos starten →